ANNUAL RESULTS
Concord Biotech Ltd.
BSE
Jun 13
2110.55
+50.30 (+ 2.44%)
Volume
4844
Prev. Close
2060.25
Open Price
2019.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
2109.70
+46.10 (+ 2.23%)
Volume
166986
Prev. Close
2063.60
Open Price
2010.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE338H01029
|
Market Cap. ( ₹ in Cr. )
|
22070.88
|
P/BV
|
13.88
|
Book Value ( ₹ )
|
152.02
|
|
BSE Code
|
543960
|
52 Week High/Low ( ₹ )
|
2664/1345
|
FV/ML
|
1/1
|
P/E(X)
|
59.39
|
|
NSE Code
|
CONCORDBIOEQ
|
Book Closure
|
29/06/2024
|
EPS ( ₹ )
|
35.52
|
Div Yield (%)
|
0.51
|
(₹ in Crs.)
| Net Sales/Income from operations | 1200.09 | 1016.94 | 830.63 | 708.44 | 603.51 |
| Other Operating Income | 0.00 | 0.00 | 22.54 | 4.49 | 12.89 |
| Total Income From Operations | 1200.09 | 1016.94 | 853.17 | 712.93 | 616.40 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 264.31 | 184.54 | 167.07 | 157.26 | 131.17 |
| Purchase of Traded Goods | 55.99 | 56.74 | 28.77 | 30.73 | 19.45 |
| Increase/Decrease in Stocks | -14.79 | -12.08 | -15.63 | -23.98 | -39.05 |
| Power & Fuel | 112.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employees Cost | 138.93 | 123.05 | 110.28 | 95.69 | 69.47 |
| Depreciation | 54.37 | 53.59 | 54.03 | 50.05 | 27.52 |
| Other Expenses | 137.08 | 233.14 | 219.39 | 179.95 | 108.26 |
| Total Expenses | 748.13 | 638.97 | 563.91 | 489.71 | 316.82 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 451.96 | 377.97 | 289.26 | 223.22 | 299.59 |
| Other Income | 44.45 | 33.78 | 35.31 | 23.42 | 14.10 |
| P/L Before Interest, Excpt. Items & Tax | 496.40 | 411.75 | 324.56 | 246.64 | 313.69 |
| Interest | 0.53 | 2.55 | 4.51 | 5.48 | 0.52 |
| P/L Before Exceptional Items & Tax | 495.88 | 409.19 | 320.05 | 241.16 | 313.17 |
| P/L Before Tax | 495.88 | 409.19 | 320.05 | 241.16 | 313.17 |
| Tax | 122.91 | 104.46 | 81.93 | 62.59 | 77.83 |
| P/L After Tax from Ordinary Activities | 372.96 | 304.73 | 238.13 | 178.57 | 235.33 |
| Net Profit/Loss For the Period | 372.96 | 304.73 | 238.13 | 178.57 | 235.33 |
| | | | | | |
| Equity Share Capital | 10.46 | 10.46 | 10.46 | 9.51 | 9.51 |
| Reserves And Surplus | 1802.18 | 1514.79 | 1281.52 | 1097.65 | 990.16 |
| Equity Dividend Rate | 1070.00 | 875.00 | 683.00 | 512.00 | 60.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.65 | 29.13 | 22.76 | 17.07 | 247.45 |
| Diluted EPS (Rs.) | 35.65 | 29.13 | 22.76 | 17.07 | 247.45 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.65 | 29.13 | 22.76 | 17.07 | 247.45 |
| Diluted EPS (Rs.) | 35.65 | 29.13 | 22.76 | 17.07 | 247.45 |
| | | | | | |
| PBITOE Margin (%) | 37.66 | 37.16 | 33.90 | 31.31 | 48.60 |
| PBTE Margin (%) | 41.31 | 40.23 | 37.51 | 33.82 | 50.80 |
| PBT Margin (%) | 41.31 | 40.23 | 37.51 | 33.82 | 50.80 |
| PAT Margin (%) | 31.07 | 29.96 | 27.91 | 25.04 | 38.17 |